Welcome to our dedicated page for Tactile Systems news (Ticker: TCMD), a resource for investors and traders seeking the latest updates and insights on Tactile Systems stock.
Tactile Systems Technology Inc (NASDAQ: TCMD) delivers innovative medical solutions for chronic conditions through advanced home therapy devices. This news hub provides investors and healthcare professionals with essential updates on corporate developments, clinical advancements, and regulatory milestones.
Track key updates including quarterly earnings reports, new product clearances, partnership announcements, and clinical study results. Our curated collection ensures access to verified press releases and objective market analysis related to lymphedema management and venous insufficiency treatments.
Discover comprehensive coverage of TCMD's operational progress, including FDA submissions, insurance reimbursement developments, and technological innovations in pneumatic compression therapy. All content is maintained to meet strict journalistic standards for accuracy and relevance in the medical device sector.
Bookmark this page for streamlined access to Tactile Systems' latest announcements and historical performance data. Check regularly for updates that could impact understanding of the company's market position in home-based chronic care solutions.
Tactile Systems Technology, Inc. (TCMD) will release its financial results for the first quarter of fiscal year 2023 on May 8, 2023, before market open.
Management will host a conference call at 5:00 p.m. ET to discuss these results, available via phone and live webcast. Tactile Medical specializes in therapies for chronic disorders like lymphedema and chronic pulmonary disease, focusing on enhancing patient care and reducing healthcare costs. The company's commitment to improving quality of life continues as it collaborates with clinicians to expand clinical evidence and access to care.
Tactile Systems Technology (TCMD) announced the appointment of Elaine Birkemeyer as Chief Financial Officer, effective March 20, 2023. She succeeds Brent Moen, who is retiring. With over 25 years of experience in finance and leadership roles at Fortune 500 companies, Birkemeyer is expected to contribute significantly to Tactile's growth strategy. She previously held key positions at UnitedHealth Group and Best Buy. The company emphasizes its leadership in at-home therapies for chronic conditions, highlighting a large addressable market and a recently strengthened financial position.
Tactile Systems Technology (Nasdaq: TCMD) has announced its participation in two upcoming virtual investor conferences:
- 33rd Oppenheimer Annual Healthcare Conference on March 13-15, with a fireside chat scheduled for March 13 at 12:40 p.m. ET.
- Sidoti Small-Cap Conference on March 22-23, with management presenting on March 22 at 2:30 p.m. ET.
Live audio webcasts of the presentations will be accessible on the company's investor relations website, along with archived replays post-conference. Tactile Medical focuses on therapies for chronic conditions, enhancing care and quality of life for patients.
Tactile Medical (TCMD) has announced a public offering of 2,500,000 shares of common stock at $13.00 per share, aiming to raise approximately $32.5 million before expenses. The underwriter, William Blair & Company, has a 30-day option to purchase an additional 375,000 shares. Proceeds from the offering will be used for expanding commercial activities, funding milestone payments, supporting new product development, and enhancing reimbursement coverage. The offering is expected to close by February 28, 2023, subject to customary conditions. This offering is conducted under a previously filed shelf registration statement with the SEC.
FAQ
What is the current stock price of Tactile Systems (TCMD)?
What is the market cap of Tactile Systems (TCMD)?
